Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L King

Showing results (161-170 of 178) with videos related to

Pageof 18
Sort By:
Cell Host & Microbe|December 6, 2023
Duffy antigen is expressed during erythropoiesis in Duffy-negative individualsCelia Dechavanne, Sebastien Dechavanne, Jürgen Bosch, et al.
Plos Neglected Tropical Diseases|February 9, 2022
Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trialLivingstone Tavul, Moses Laman, Cade Howard, et al.
Medrxiv : the Preprint Server for Health Sciences|February 7, 2023
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workersClare Nugent, Yasin Abul, Elizabeth White, et al.
Vaccine|January 25, 2026
Antibody responses to SARS-CoV-2 vaccine in nursing home residents support a Bi-annual update scheduleAlexandra N Paxitzis, Oladayo A Oyebanji, Olajide J Olagunju, et al.
Vaccine|September 2, 2023
Rheumatoid arthritis and older age are associated with lower humoral and cellular immune response to primary series COVID-19 mRNA vaccineHolly M Dudley, Megan O'Mara, Ann Auma, et al.
Vaccine|April 28, 2023
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workersClare Nugent, Yasin Abul, Elizabeth M White, et al.
Plos Medicine|June 25, 2019
The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized studyGary J Weil, Joshua Bogus, Michael Christian, et al.
Elife|September 27, 2017
Identification of highly-protective combinations of <i>Plasmodium vivax</i> recombinant proteins for vaccine developmentCamila Tenorio França, Michael T White, Wen-Qiang He, et al.
MMWR. Morbidity and Mortality Weekly Report|January 26, 2023
SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022David H Canaday, Oladayo A Oyebanji, Elizabeth M White, et al.
Plos Neglected Tropical Diseases|March 3, 2021
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasisAlison Krentel, Nandha Basker, Madsen Beau de Rochars, et al.
Pageof 18

Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
Cell Host & Microbe|December 6, 2023
Duffy antigen is expressed during erythropoiesis in Duffy-negative individualsCelia Dechavanne, Sebastien Dechavanne, Jürgen Bosch, et al.
Plos Neglected Tropical Diseases|February 9, 2022
Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trialLivingstone Tavul, Moses Laman, Cade Howard, et al.
Medrxiv : the Preprint Server for Health Sciences|February 7, 2023
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workersClare Nugent, Yasin Abul, Elizabeth White, et al.
Vaccine|January 25, 2026
Antibody responses to SARS-CoV-2 vaccine in nursing home residents support a Bi-annual update scheduleAlexandra N Paxitzis, Oladayo A Oyebanji, Olajide J Olagunju, et al.
Vaccine|September 2, 2023
Rheumatoid arthritis and older age are associated with lower humoral and cellular immune response to primary series COVID-19 mRNA vaccineHolly M Dudley, Megan O'Mara, Ann Auma, et al.
Vaccine|April 28, 2023
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workersClare Nugent, Yasin Abul, Elizabeth M White, et al.
Plos Medicine|June 25, 2019
The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized studyGary J Weil, Joshua Bogus, Michael Christian, et al.
Elife|September 27, 2017
Identification of highly-protective combinations of <i>Plasmodium vivax</i> recombinant proteins for vaccine developmentCamila Tenorio França, Michael T White, Wen-Qiang He, et al.
MMWR. Morbidity and Mortality Weekly Report|January 26, 2023
SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022David H Canaday, Oladayo A Oyebanji, Elizabeth M White, et al.
Plos Neglected Tropical Diseases|March 3, 2021
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasisAlison Krentel, Nandha Basker, Madsen Beau de Rochars, et al.
Pageof 18